MACQUARIE GROUP LTD - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 198 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.

Quarter-by-quarter ownership
MACQUARIE GROUP LTD ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$240,000
-53.8%
400,0000.0%0.00%
-100.0%
Q2 2023$520,000
-26.1%
400,0000.0%0.00%0.0%
Q1 2023$704,000
-43.9%
400,0000.0%0.00%0.0%
Q4 2022$1,256,000
-36.2%
400,000
-0.1%
0.00%
-50.0%
Q3 2022$1,970,000
+18.3%
400,260
-0.5%
0.00%0.0%
Q2 2022$1,665,000
-28.7%
402,1350.0%0.00%0.0%
Q1 2022$2,336,000
-22.5%
402,1350.0%0.00%
-33.3%
Q4 2021$3,016,000
-16.8%
402,1350.0%0.00%0.0%
Q3 2021$3,623,000
-24.7%
402,1350.0%0.00%
-25.0%
Q2 2021$4,814,000
-4.7%
402,135
-0.2%
0.00%
-42.9%
Q1 2021$5,051,000
-19.3%
403,111
+0.5%
0.01%
-22.2%
Q4 2020$6,262,000
+65.1%
401,2810.0%0.01%
+50.0%
Q3 2020$3,792,000
+4.6%
401,281
-0.8%
0.01%0.0%
Q2 2020$3,624,000
+42.2%
404,518
+1.1%
0.01%
+20.0%
Q1 2020$2,548,000
-23.9%
400,0000.0%0.01%0.0%
Q4 2019$3,348,000
-7.5%
400,0000.0%0.01%
-16.7%
Q3 2019$3,620,000
-72.0%
400,000
-66.7%
0.01%
-14.3%
Q2 2019$12,924,000
+1078.1%
1,200,000
+943.5%
0.01%
+250.0%
Q1 2019$1,097,000
+77.5%
115,000
+113.5%
0.00%
+100.0%
Q4 2018$618,000
-30.5%
53,852
+2.7%
0.00%0.0%
Q3 2018$889,000
+12.2%
52,452
-5.9%
0.00%0.0%
Q2 2018$792,000
+24.1%
55,762
+66.1%
0.00%0.0%
Q1 2018$638,000
+93.3%
33,566
+67.0%
0.00%0.0%
Q4 2017$330,000
+1122.2%
20,100
+1016.7%
0.00%
Q3 2017$27,0001,8000.00%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
RA Capital Management 6,000,000$66,540,0006.69%
FIC CAPITAL INC 787,529$8,734,0003.47%
RA Capital Management 1,220,209$13,532,0001.36%
PRINCETON CAPITAL MANAGEMENT INC 114,120$1,266,0000.67%
Perceptive Advisors 800,000$8,872,0000.53%
Cormorant Asset Management, LP 361,000$4,003,0000.53%
Highlander Capital Management, LLC 43,500$482,0000.43%
APEX CAPITAL, LLC 439,900$4,878,0000.42%
WASATCH ADVISORS LP 3,091,386$34,283,0000.37%
Baker Brothers Advisors 3,230,932$35,831,0000.31%
View complete list of SANGAMO THERAPEUTICS INC shareholders